Navigation Links
Auxilium Pharmaceuticals, Inc. to Present At The Oppenheimer 23rd Annual Growth Conference
Date:12/7/2012

looking statements due to various factors, including further evaluation of clinical data, results of clinical trials, decisions by regulatory authorities as to whether and when to approve drug applications, and general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries and those discussed in Auxilium's Annual Report under the heading "Risk Factors" on Form 10-K for the year ended December 31, 2011, and Form 10-Q for the quarter ended September 30, 2012, which are on file with the Securities and Exchange Commission (the "SEC") and may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of Auxilium's home page on the Internet at http://www.Auxilium.com under the heading "For Investors -- SEC Filings." There may be additional risks that Auxilium does not presently know or that Auxilium currently believes are immaterial which could also cause actual results to differ from those contained in the forward-looking statements. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements.

In addition, forward-looking statements provide Auxilium's expectations, plans or forecasts of future events and views as of the date of this release. Auxilium anticipates that subsequent events and developments will cause Auxilium's assessments to change. However, while Auxilium may elect to update these forward-looking statements at some point in the future, Auxilium specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing Auxilium's assessments as of any date subsequent to the date of this release.For More Information, Contact:James E. Fickenscher / CFO

William Q. Sargent, Jr. / V.P., IR
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
2. Auxilium Pharmaceuticals, Inc. to Present At The JMP Securities 2012 Healthcare Conference
3. Auxilium Pharmaceuticals, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
4. Auxilium Announces Appointments to Enhance Leadership Team
5. Ampio Pharmaceuticals, Inc. (AMPE) announces appointment of Josh Disbrow as Chief Operating Officer effective December 15, 2012
6. OncoGenex Pharmaceuticals, Inc. Provides Clinical Development Update and Reports Financial Results for Third Quarter 2012
7. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2012 Financial Results
8. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess of $100,000 Investing In Keryx Biopharmaceuticals, Inc. To Contact the Firm
9. FierceBiotech Names Enanta Pharmaceuticals, Inc. a Fierce 15 Winner
10. MAP Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
11. Silence Therapeutics Partner, Quark Pharmaceuticals, Extends its Agreement With Pfizer to Develop one of Its Compounds Containing Silences AtuRNAi in a New Indication
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... SAS today announced that data related to its lead ... 1A (CMT1A), is being presented in four posters and one ... Meeting at the Quebec Congress Center in Quebec ... At Poster Viewing Session 4, four posters will ... Poster 23: "A Meta-Analysis Of Randomized Double-Blind ...
(Date:6/29/2015)... -- MiMedx Group, Inc. (NASDAQ: MDXG ), the leading ... processes to develop and market advanced products and therapies ... Ophthalmic and Dental sectors of healthcare, announced that its ... awarded the Lifetime Achievement Award in the EY Entrepreneur ... The Entrepreneur Of The Year Program, now in its ...
(Date:6/29/2015)... , June 29, 2015   For the seventh year ... to assess their overall digital maturity called the ... these companies are not maturing fast enough. While it,s ... in numerous ways overall and customers are increasingly "digital ... of digital customer engagement.  ...
(Date:6/26/2015)... ... 2015 , ... Charm Sciences, Inc. is pleased to announce ... (GIPSA) awarded a five year contract to Charm Sciences to monitor Deoxynivalenol (DON), ... Test. This 5 minute quantitative test extracts DON from samples using water. , ...
Breaking Biology Technology:Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2EY Entrepreneur Of The Year Program Recognizes Pete Petit, The Chairman & CEO of MiMedx 2Results from Digital Maturity Study Show Pharma Lagging 2Results from Digital Maturity Study Show Pharma Lagging 3Results from Digital Maturity Study Show Pharma Lagging 4USDA-GIPSA (FGIS) Awards 5 Year Contract for Vomitoxin Tests to Charm Sciences 2
... , , , ... 20 The Molecular Genetics Core Facility (MGCF) at ... genetics researchers to conduct the highly economic targeted enrichment of ... will be receiving the Geniom RT Analyzer® from febit to ...
... , Washington , Jan. ... Alnylam announced today that the organizations are partnering to engage the ... and Alnylam Intellectual Property (IP) Pool.  The IP Pool was formed ... development of new medicines for the treatment of 16 neglected tropical ...
... ... (IPS), a leading, full-service engineering, construction, commissioning and qualification company dedicated to assisting ... Wareheim as Bioprocess Subject Matter Expert. , ... Lafayette Hill, PA (Vocus) January 20, 2010 ...
Cached Biology Technology:Molecular Genetics Core Facility at Children's Hospital Boston Selects HybSelect from febit for Targeted Resequencing 2Molecular Genetics Core Facility at Children's Hospital Boston Selects HybSelect from febit for Targeted Resequencing 3BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool 2BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool 3BIO Ventures for Global Health Chosen to Administer the GSK and Alnylam Intellectual Property Pool 4IPS Appoints Dave Wareheim as Bioprocess Subject Matter Expert 2IPS Appoints Dave Wareheim as Bioprocess Subject Matter Expert 3
(Date:6/23/2015)... Minn. , June 23, 2015   ... company that supports the entire spectrum of clinical ... iMedNet ™ , the company,s intuitive, ... been awarded a Silver 2015 Stevie® Award by ... Health Products & Services Website category.  The American ...
(Date:6/18/2015)... , June 18, 2015 This report analyzes ... by the following Product Segments, which includes Immunoassay Analyzers ... Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. ... Canada , Japan ... , Latin America , and ...
(Date:6/17/2015)... June 17, 2015  Synaptics Inc. (NASDAQ: ... today announced that Xiaomi, one of the world,s ... ClearPad ® family of capacitive touchscreen ... circuits (DDICs) for its latest smartphones, the Xiaomi ... for full in-cell display solutions and DDICs in ...
Breaking Biology News(10 mins):MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2Global Immunoassay Systems Market 2Global Immunoassay Systems Market 3Global Immunoassay Systems Market 4Global Immunoassay Systems Market 5Global Immunoassay Systems Market 6Global Immunoassay Systems Market 7Global Immunoassay Systems Market 8Global Immunoassay Systems Market 9Global Immunoassay Systems Market 10Global Immunoassay Systems Market 11Global Immunoassay Systems Market 12Global Immunoassay Systems Market 13Global Immunoassay Systems Market 14Global Immunoassay Systems Market 15Global Immunoassay Systems Market 16Global Immunoassay Systems Market 17Global Immunoassay Systems Market 18Global Immunoassay Systems Market 19Global Immunoassay Systems Market 20Global Immunoassay Systems Market 21Global Immunoassay Systems Market 22Global Immunoassay Systems Market 23Global Immunoassay Systems Market 24Global Immunoassay Systems Market 25Global Immunoassay Systems Market 26Global Immunoassay Systems Market 27Global Immunoassay Systems Market 28Global Immunoassay Systems Market 29Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 2Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomi's Latest Flagship Smartphones 3
... be the key to creating cyborg interfaces? Circuitry that links ... such as a robotic limb or artificial eye might one ... Writing in the International Journal of Medical Engineering ... "memristor" can be made using human blood. Memristors were a ...
... (Baltimore, MD) Today, the Interactive Autism Network (IAN), ... first major survey to study the experience of wandering ... disorders (ASD). The tendency of individuals with ASD to ... injury or even death, yet information on this critical ...
... State University has revealed a potential new way for plants ... and molecular biology professor, cites that this defense mechanism is ... plants and herbivores. Howe, in the current issue of ... offers insights to understanding the chemical weaponry of this war, ...
Cached Biology News:Blood simple circuitry for cyborgs 2Why do children with autism wander and bolt from safe places? 2The way to (kill) a bug's heart is through its stomach 2
Mouse monoclonal antibody raised against a partial recombinant ALPK3. NCBI Entrez Gene ID = ALPK3...
Mouse monoclonal antibody raised against a partial recombinant MYO7A. NCBI Entrez Gene ID = MYO7A...
... Cell Lines ,High Quality, Functionally-Validated, Ion Channel ... known for having a critical role in ... a key function in pain, CNS and ... have been investigated in therapeutic areas, such ...
Mouse monoclonal antibody raised against a partial recombinant ENTPD5. NCBI Entrez Gene ID = ENTPD5...
Biology Products: